Based on recent SCRS survey data, a vast majority of research sites (58%) anticipate that COVID-19 will negatively affect their clinical trial enrollment and nearly half of respondents (47%) feel COVID-19 will have a negative effect on retention. With the number of...

The FDA recently released new guidance on clinical trials in the face of COVID-19. In their published report, FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic, they acknowledged that challenges may arise in ongoing trials. For...

Clinical studies are carefully designed to address the unique needs of not only the sponsor, but more importantly, the patients that commit to participate. Depending on the nature and severity of the condition, study lengths vary. A cardiovascular outcome trial...

The Coronavirus Disease 2019 (COVID-19) is wreaking havoc around the globe. With a seemingly imminent pandemic on the horizon, healthcare organizations are rushing to prepare for the fallout. The Centers for Disease Control and Prevention warned that it expects the...

Clinical trials require a significant commitment from patients, particularly in regard to travel time to research sites for regular visits. Consider the additional patient burden involved in clinical trials for patients with paralysis, dementia, or other conditions...

Clinical research is a critical component in determining the safety and effectiveness of medications, devices, and treatment regimens. Whether used for prevention, treatment, diagnosis or simply symptom relief, the pharmaceutical industry relies on clinical...

Clinical research sites have a lot to gain from incorporating decentralized clinical trials into their practices. Though the technology is commonly touted as a benefit to sponsors and patients, there are just as many advantages for research sites. As the addition of...